Access to this article is restricted until 6 months after publication by request of the publisher. Restriction lift date: 2024-11-10
Bacteriocin diversity, function, discovery and application as antimicrobials
dc.check.date | 2024-11-10 | en |
dc.check.info | Access to this article is restricted until 6 months after publication by request of the publisher | en |
dc.contributor.author | Sugrue, Ivan | en |
dc.contributor.author | Ross, R. Paul | en |
dc.contributor.author | Hill, Colin | en |
dc.date.accessioned | 2024-07-02T14:50:32Z | |
dc.date.available | 2024-07-02T14:50:32Z | |
dc.date.issued | 2024-05-10 | en |
dc.description.abstract | Bacteriocins are potent antimicrobial peptides that are produced by bacteria. Since their discovery almost a century ago, diverse peptides have been discovered and described, and some are currently used as commercial food preservatives. Many bacteriocins exhibit extensively post-translationally modified structures encoded on complex gene clusters, whereas others have simple linear structures. The molecular structures, mechanisms of action and resistance have been determined for a number of bacteriocins, but most remain incompletely characterized. These gene-encoded peptides are amenable to bioengineering strategies and heterologous expression, enabling metagenomic mining and modification of novel antimicrobials. The ongoing global antimicrobial resistance crisis demands that novel therapeutics be developed to combat infectious pathogens. New compounds that are target-specific and compatible with the resident microbiota would be valuable alternatives to current antimicrobials. As bacteriocins can be broad or narrow spectrum in nature, they are promising tools for this purpose. However, few bacteriocins have gone beyond preclinical trials and none is currently used therapeutically in humans. In this Review, we explore the broad diversity in bacteriocin structure and function, describe identification and optimization methods and discuss the reasons behind the lack of translation beyond the laboratory of these potentially valuable antimicrobials. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Sugrue, I., Ross, R. P. and Hill, C. (2024) 'Bacteriocin diversity, function, discovery and application as antimicrobials', Nature Reviews Microbiology. https://doi.org/10.1038/s41579-024-01045-x | en |
dc.identifier.doi | https://doi.org/10.1038/s41579-024-01045-x | en |
dc.identifier.eissn | 1740-1534 | en |
dc.identifier.issn | 1740-1526 | en |
dc.identifier.journaltitle | Nature Reviews Microbiology | en |
dc.identifier.uri | https://hdl.handle.net/10468/16089 | |
dc.language.iso | en | en |
dc.publisher | Springer Nature | en |
dc.rights | © 2024, Springer Nature Limited. This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1038/s41579-024-01045-x | en |
dc.subject | Bacteriocins | en |
dc.subject | Antimicrobial | en |
dc.subject | Infectious pathogens | en |
dc.title | Bacteriocin diversity, function, discovery and application as antimicrobials | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- Rev_Hill_NRMICRO-23-082_-_FE_ADT_March_1710230757_1_acceptedversion.pdf
- Size:
- 2.15 MB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted Version
Loading...
- Name:
- Rev_Hill_NRMICRO-23-082_-_FE_ADT_March_1710230757_1_acceptedversion.docx
- Size:
- 2.68 MB
- Format:
- Microsoft Word XML
- Description:
- Authors' original accepted version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: